Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated drug candidates where the presence of fluorine atoms enhances metabolic stability and bioavailability. The nitro group allows for further functionalization, such as reduction to an amine, enabling coupling reactions to form active pharmaceutical ingredients. The benzyloxy moiety acts as a protecting group for phenolic hydroxyls during multi-step syntheses. Commonly employed in research settings for constructing complex molecules in medicinal chemistry, especially in the design of kinase inhibitors and anti-inflammatory agents.